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Abstract
Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of beta cells in the pancreas. Little is known about
the in vivo dynamic interactions between T cells and beta cells or the kinetic behavior of other immune cell subsets in the
pancreatic islets. Utilizing multiphoton microscopy we have designed a technique that allows for the real-time visualization of
diabetogenic T cells and dendritic cells in pancreatic islets in a live animal, including their interplay with beta cells and the
vasculature. Using a custom designed stage, the pancreas was surgically exposed under live conditions so that imaging of
islets under intact blood pressure and oxygen supply became possible. We demonstrate here that this approach allows for the
tracking of diabetogenic leukocytes as well as vascularization phenotype of islets and accumulation of dendritic cells in islets
during diabetes pathogenesis. This technique should be useful in mapping crucial kinetic events in T1D pathogenesis and in
testing the impact of immune based interventions on T cell migration, extravasation and islet destruction.
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Introduction
In type 1 diabetes (T1D), destruction of beta cells located in the
islets of Langerhans throughout the pancreas is extremely difficult
to study owing to the organ’s inaccessible location, diffuse tissue
architecture and abundance of potentially harmful digestive
enzymes that make it difficult to obtain biopsy tissue samples[1].
Despite some differences compared to the human pathophysiol-
ogy, our knowledge of how T1D develops has benefited
significantly from studies in rodent models such as the non-obese
diabetic mouse (NOD)[2]. In mouse and man, documentation of
autoimmune events in the pancreatic islets (a process termed
‘insulitis’) has been traditionally achieved by histological tech-
niques in cross-sectional studies[3]. While such data provide a one-
time ‘snapshot’ of islet destruction, there is no clear knowledge of
the precise cellular dynamics involved in this process.
Since first reported by Denk and coworkers[4], two-photon
microscopy has been applied extensively to image immune cells in
intact lymphoid organs[5,6]. The major advancement associated
with the technique is the use of a pulsed infrared laser for
fluorescent dye excitation[7]. This high excitation wavelength
allows for deep tissue imaging and its low energy constrained to
the focal plane limits phototoxicity. As a consequence, two-photon
microscopy has become the technique of choice to assess the
dynamic behavior of immune cells in vivo. To date, however, the
handful of studies that applied two-photon microscopy in the
context of autoimmune diabetes were limited to the pancreatic
draining lymph nodes[8,9,10], whereas the situation in the
pancreas remains uncharted territory. One group performed 2-
photon microscopy on islets transferred into the anterior chamber
of the eye, but the immune privileged nature of the site precludes
inclusion of the hallmark autoimmune component of T1D[11].
Another recent study by Nyman et al introduced the use of
intravital, high-speed confocal scanning in order to determine
blood flow dynamics in islets[12]. The latter approach, however,
poses considerable constraints in terms of imaging depth and laser
cytotoxicity and thus is unsuitable for tracking immune cells
around islets over longer time spans.
The dynamic behavior of immune cells is profoundly dependent
on physiological conditions[13], and it is particularly questionable
whether circulatory deprivation in explanted pancreas preparations
would leave the true in situ parameters of diabetogenic immune
responses unaltered. We report here a novel approach to visualize
the kinetic properties of immune cells during the development of
diabetes in the intact pancreas and islets of living animals. As such,
we provide the first real-time visualization of leukocyte-beta cell
interactions and dendritic cell recruitment to the islets.
Results
Design of a surgical approach for intravital two-photon
studies in the pancreas
The anatomical location of the pancreas, in between the curve
of the duodenum (widest part; ‘head’) and the spleen (smallest part;
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‘tail’), calls for a careful approach to avoid potentially fatal organ
damage or bleeding during imaging (Figure 1A). In addition, the
pancreas is softer and less compactly organized than most other
organs, requiring avoidance of excessive force during exposition.
We chose to seek access from the splenic side and image the tail
region after cauterization of the splenic arteries. This leaves the
vascular supply originating from the superior and inferior
pancreaticoduodenal arteries intact. Successful intravital two-
photon imaging is dependent on 3 major factors: (1) immobiliza-
tion of the tissue to minimize movement artifacts; (2) immersion in
heated buffer at precise physiological temperature for use with a
water dipping objective; (3) proper maintenance of anesthesia and
body temperature of the animal. We built a custom-designed
reservoir and incorporated a heating supply to satisfy these
requirements (Figure 1B). In this way, the tail region of the
pancreas could be gently exposed and its outer edges glued to an
imaging pedestal. The surrounding buffer was maintained at 37uC
by a recirculation system, which has the combined benefit that the
animal’s body temperature is preserved. Importantly, the animal’s
abdominal area itself was not exposed to the buffer, as water influx
was prevented by a small plastic barrier sealed with Vaseline in
between the inner reservoir and the imaging pedestal. Applying
Vaseline ensures proper sealing while avoiding any pressure on the
tissue that may block circulation. The minor remaining breathing
artifact was corrected post acquisition by use of the ImageJ
registration plugins TurboReg and StackReg[14]. Typical in vivo
2D islet morphology as imaged by two-photon microscopy is
depicted in Figure 1C and as a 3D rotating rendering in Movie S1.
This intravital approach has the notable advantage of allowing for
detailed visualization of pancreatic islet vasculature, as is achieved
by intravenous injection of fluorescently labeled agents (Figure 1D;
Movie S2). Moreover, the intact structural integrity of the local
microvessels clearly indicates that sufficient blood supply is
maintained around the islet site and adds physiological significance
to our findings.
Determining leukocyte motility and interactions with
beta cells in the pancreas
We have previously established an antigen-specific, virus-free
model of beta cell destruction that relies on adoptive transfer of
CD8 T cells ([15] and manuscript in press[16]). In brief, breaking
tolerance to enable these cells to access the islets requires a
remarkably extensive stimulation protocol, mimicking some of the
effects of acute viral infection by repeated stimulation, immuni-
zation and TLR ligation (Figure 2A). As a result, recipient mice
develop diabetes in a highly synchronized fashion 9–10 days after
transfer (Figure 2B). Prior to in vivo microscopy, we characterized
the phenotype of the T cells within the transferred population at
Figure 1. Surgical approach and maintenance of physiologic conditions during intravital imaging of the pancreas. A. Schematic
overview of the anatomical orientation of the pancreas in rodents. In order to gain access to the pancreatic tail region, we cauterized the splenic
vessels and performed a splenectomy. The red rectangle indicates the region of the pancreas subjected to imaging. B. Design of a custom-made
imaging reservoir for two-photon imaging of the pancreas. The outer reservoir is filled with saline buffer, covers the organ and is continuously
maintained between 36.5 and 37 degrees Celcius by a recirculation system. The inner reservoir containing the animal is sealed from the buffer by a
barrier (black) and a demountable bridge at the site of the imaging pedestal. To achieve sealing without pressuring the tissue, Vaseline is applied
between bridge and pancreas. The pancreatic tail region is gently exposed and its outer edges attached to the pedestal with surgical glue. Finally, the
water dipping objective is lowered onto the pancreas for imaging. C. Typical in vivo appearance of a healthy islet, showing coherent beta cell
architecture and uniform GFP expression (MIP of 76 z-planes spaced 2 mm; pixel w/h: 1.2 mm; corresponds to Movie S1). D. Islet microvasculature (red)
as revealed by intravital imaging after injection of Texas-Red labeled dextran. (MIP of 43 z-planes spaced 5 mm; pixel w/h: 0.6 mm). Scale bars in C and
D are 100 mm.
doi:10.1371/journal.pone.0015732.g001
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diabetes onset in the pancreas (Figure 2C). Transferred cells that
migrated into the pancreas had vigorously proliferated, acquired
an effector memory phenotype, and were producing considerable
amounts of IFN-a˜. Our intent was to enhance our chances of
detecting transferred cells around the limited population of islets
accessible by two-photon microscopy through the acute and
synchronized nature of autoimmune diabetes observed in this
model. From earlier studies we concluded that the optimal time
window for imaging of T cells and beta cells was on day 7–8, right
before onset of clinical diabetes.
We applied the peptide/adjuvant-induced model to capture the
invasion process within islets at various stages of destruction
(Figure 3; Movie S3). For these studies, we crossed the CD8-TcR
transgenic P14 strain to mice ubiquitously expressing the red
fluorescent protein DsRed[17]. This setup allowed us to track ‘red’
CD8 T cells to attack ‘green’ islets and achieve sufficient spatial
resolution to characterize CD8 T cell-beta cell contacts.
Especially in Figure 3B, the coherent GFP signal as observed
under baseline conditions (see Figure 1C) is fragmented over what
appear to be numerous small apoptotic vesicles. In these proof-of-
concept studies we transferred unpurified splenocytes in order to
replicate the high diabetes incidence as presented in Figure 2B.
Considering that P14 mice typically harbor only ,2% CD4 T
cells in their splenocyte population, we therefore assume that the
majority of visualized events were CD8 T cells and that B
cells were the second most frequent population during the late
stages of insulitis, similar to what is observed in human islet
pathology[18].
After image registration in order to eliminate the breathing
artifact, three-dimensional tracking was performed on the time
series depicted in Movie S3 (Figure 3A–C). Calculation of mean
track velocities revealed variable cellular speeds, and most
velocities are broadly within the range observed previously by
tracking of T cells in the lymph nodes[5]. Interestingly, cellular
velocities were markedly lower (P=0.0021 versus 3A; P=0.0038
versus 3C) around the islet that showed incoherent GFP signal
(3B). Particularly in this movie S3B, cellular arrest in the proximity
of beta cells became prevalent (Figure 3D; Movie S4) as evidenced
by the high arrest coefficients (Figure 3B; P=0.0328 versus 3A
and P=0.0834 versus 3C). However, we found that only a minor
fraction of the cells established prolonged interactions with the
beta cells, but in these cases a stable interaction could last for more
than an hour (Figure 3A,B). In general, stable contacts with beta
cells were rare, as for instance only 1 cell was found to establish
prolonged interaction in movie S3C.
Given the extensive amount of inflammation observed in Movie
S3 (particularly right panel), we expected to see some of the beta
cells become GFP negative over time as they would commit to
apoptosis. However, beta cell apoptosis was only rarely detected
during our imaging time frame of 1–4 hours, despite the high
numbers of diabetogenic CD8 T cells present and further studies
are underway to precisely quantify such events.
Figure 2. An acute diabetes model suitable for in vivo pancreas imaging. A. Genetically labeled GP33-specific (‘P14’) splenocytes were
adoptively transferred into fluorescent reporter mice harboring green beta cells that express LCMV-GP antigen. The cells were stimulated in vivo by
repeated stimulation with peptide, CpG and Poly-IC (TLR ligation). B. These mice develop highly synchronized autoimmune diabetes with clinical
onset between day 9–10. BGM: blood glucose measurement C. Pancreatic draining lymph nodes (PLN) and pancreas (PAN) were harvested at time of
onset (day 8 post transfer) and stained for the P14 TCR chains Va´2 and Vaˆ8.1/2, CD8a´, CD69, CD44 and CD62L. In conjunction with CFSE dilution and
ICCS for IFN-a˜, this analysis reveals the influx of highly activated, memory phenotype GP33-specific CD8 T cells around the time of onset. PLN cells
from naı¨ve animals were used as controls for comparison since none of the cells homed to the pancreas in the absence of stimulation.
doi:10.1371/journal.pone.0015732.g002
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We conclude that our approach enables us to efficiently detect
the kinetics of autoreactive immune cells in the proximity of
pancreatic islets during diabetes development.
Imaging dendritic cells under steady-state versus insulitic
conditions
The CD11c-eYFP reporter mouse represents a valuable tool for the
efficient detection of endogenous dendritic cells by two-photon
microscopy[19]. Under baseline conditions, dendritic cells in the
pancreas are predominantly slowly moving cells (Figure 4B,C; Movie
S5) and, except for ,10 intra-islet DC’s[20], are not significantly
associated with the islets (Figure 4A; Movie S5). The cells spent a
significant portion of their time in virtual arrest (Figure 4B, D). In line
with a report by Calderon et al, we find that dendritic cells maintain
intimate contacts with the local microvasculature[20] (Figure 4E,
Movie S5 right panel). The constant extension/retraction of processes
could be seen, characteristic of their constant environmental sampling.
Upon induction of diabetes, however, dendritic cells were found
to accumulate in dense clusters around the islets, wedging in
between the remaining beta cells (Figure 4F; Movie S6). Dendritic
cells were seen to be gradually recruited to the site of inflammation
(Movie S6, arrows in left panel). Under these conditions, dendritic
cells virtually arrest at the site of inflammation (Figure 4G,H).
Discussion
We have presented here an in vivo approach to visualize the
cellular kinetics of diabetes development in a novel adoptive transfer
model based on the well-studied viral RIP-LCMVmodel. In a 2008
review article, we previously theorized an approach for ‘real-time
imaging of the pancreas during development of diabetes’, based on
our experience with an inverted confocal microscope[15]. Upon
implementation, we found here that the diabetes transfer model
proposed in that article is indeed suitable for imaging purposes but
its rudimentary surgical approach was soon abandoned.
Taking into account the notorious inaccessibility of the pancreas
for in vivo studies we have taken advantage of two-photon micro-
scopy for deep-tissue intravital imaging of cellular interactions in an
intact soft organ. In doing so, we provide a first impression of the
dynamic interplay between diabetogenic immune cells and beta
cells.
Advantages
First, we developed a surgical procedure which allows us to
expose the pancreatic tail region to the extent that it could be
placed under our upright microscope objective. We estimate that
this technique enables us to access approximately one third of the
Figure 3. In vivo imaging captures T cell motility and interactions with beta cells in the pancreas. A. Corresponds to left panel of Movie S3
(MIP from 15 z planes, 11 mm apart, pixel w/h: 0.6 mm). Mean track velocities, arrest coefficients and beta cell contact times were determined after 3D
tracking. B. As immune-mediated destruction advances, the GFP signal disintegrates in what appear to be multiple small GFP-containing vesicles (MIP
from 15 z planes, 12 mm apart, pixel w/h: 0.9 mm; corresponds to middle panel of Movie S3). Mean track velocities, arrest coefficients and beta cell
contact times were determined after 3D tracking. C. Reduced islet size and considerable infiltrate is observed (MIP from 15 z planes, 7.2 mm apart,
pixel w/h: 0.5 mm; corresponds to right panel of Movie S3). Only mean track velocities and arrest coefficients were determined as only 1 cell was found
to establish prolonged contact with beta cells. D. Isosurface rendition of a T cell (red) in contact with beta cells (green), derived from Movie S4 (left
panel). White scale bars are 100 mm, except for D, 10 mm.
doi:10.1371/journal.pone.0015732.g003
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pancreas from the tail side. Any islet in that region, regardless of its
size, can be reliably visualized, provided it lies close enough to the
surface (,250 mm two-photon depth limit).
We next built a custom-designed imaging reservoir enabling
proper maintenance of hydration and tight temperature control.
To date, Nyman et al were the only group to achieve in vivo
imaging of pancreatic beta cells at cellular resolution[12]. Our
present method not only offers improved physiological control but,
in conjunction with adoptive transfer of fluorescently labeled
effector cells, allows for visualization of diabetogenic responses in
situ. Like in the work by Nyman et al, microvascular blood flow is
maintained around the islets in our studies and accentuates the
validity of our intravital approach with respect to obtaining
physiologic, meaningful results.
An acute transfer model for autoimmune diabetes was employed
by introduction of fluorescently labeled splenocytes harboring
diabetogenic TCR-transgenic CD8 T cells into recipients express-
ing both antigen and GFP in their beta cells. We propose that two
factors are pivotal for successful two-photon imaging of islet
autoimmunity: induction of synchronized insulitis and genetic
labeling of the transferred cell population with a strong fluorophore.
The first requirement is associated with the limited amount of islets
that are close enough to the surface to be scanned by common two-
photon microscopy systems. Synchronicity of beta cell decay by use
of an aggressive, acute-onset induction protocol therefore enhances
the chances of capturing beta cell destruction in real-time. In
conjunction with the availability of mice expressing GFP under the
insulin promoter in both B6 and NOD background and strains
expressing red or far-red fluorophores controlled by a variety of
promoters, we believe there is ample opportunity to translate our
approach to other diabetes models. In the NOD mouse, several
options exist to synchronize/accelerate insulitis such as injection of
cyclophosphamide[21], adoptive transfer of highly diabetogenic T
cell clones[22] or even viral infection with coxsackievirus[23].
Limitations
In advancing two-photon microscopy towards in vivo imaging of
the pancreas, we have encountered some limitations that are
inherent to deep-tissue imaging. The micrometer resolution in
conjunction with the high number of optical stacks required for
reconstruction of an islet over time introduces a considerable
breathing artifact. We successfully corrected for this using
commonly available software, avoiding image distortion or
affecting the results of cellular tracking.
In the current study, we aimed to capture ongoing insulitis
within entire islets. The z-step size we used to acquire such large
volumes is higher than the conventionally used five microns[24,25]
and likely introduces some degree of inaccuracy in determining the
center of cell mass during 3D tracking. In particular some
broadening can be expected in the velocity distribution[26]. That
said, smaller z-stepping is certainly possible for more precise
measurements of e.g. instantaneous velocity of individual cells in
the islets, but will come at the expense of captured cell numbers,
which in our case are scattered around the pancreatic islet.
Since the imaging depth is in the order of a few hundred mm,
only the most superficial subset of islets is accessible. It is
conceivable that this restraint leads to some degree of experimen-
tal bias as the largest islets are predominantly located in the core of
Figure 4. Pancreatic dendritic cells constitute a static population in the steady state, but are recruited to the islets under conditions
of inflammation. A. Dendritic cells (yellow) can be seen in the normal pancreas at relatively low densities, in no particular association with the islets
(MIP of 35 slices spaced 8 mm apart; pixel w/h: 1.5 mm; corresponds to Movie S5, left panel). Injection of a Texas-Red labeled dextran reveals the dense
vascular network (magenta) in the pancreas. Yellowish color of the islets is due to spectral bleedthrough. B,C,D. Tracking of DC in the exocrine
pancreas under normal conditions was performed in triplicate (representative experiment in B) and shows low average track velocities (C) and a high
portion of cells that virtually arrested during imaging as judged from their arrest coefficients (D). E. Dendritic cells remain in close interaction with the
local microvasculature under normal conditions. Images are MIPs spanning total z-volumes of 50 to 70 mm with a step size of 3 to 5 mm. Pixel w/h:
0.3 mm (lower planes), 0.2 and 0.1 mm (upper left and right, resp.). F. Upon diabetes induction, DC accumulate (MIP of 30 planes spaced 6 mm apart;
pixel w/h: 1.5 mm; corresponds to Movie S6, middle panel) and completely arrest for prolonged periods of time in dense clusters, wedged in an
around the islets. Tracking of CD11c+ cells in the exocrine pancreas showed little motility (G, H) Experiments were performed in triplicate (see 3
panels in Movie S6). The vasculature can be seen in red. White scale bars are 100 mm, except E, 10 mm. All tracking data are representative of
duplicate experiments.
doi:10.1371/journal.pone.0015732.g004
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the pancreas. On the other hand, it was shown previously that the
smallest, peripherally located islets are the first to be destroyed
during diabetes development in the NOD model[27]. This
population may therefore in the NOD mouse constitute an ideal
target for imaging T cell behavior at the stage of early immune-
mediated beta cell loss.
This technique is to be considered terminal and is therefore not
intended for extended longitudinal studies of beta cell mass
fluctuation. The imaging time is in the order of hours and is thus
relatively short in comparison to body window-enabled methods
[28]. Techniques such as in vivo optical coherence microscopy[29]
or ex vivo optical projection tomography[27] are more suitable for
the purpose of following beta cell mass over time but are currently
restricted to imaging at islet resolution. Instead, the technique
presented here is designed to image individual T cell interactions
with beta cells in vivo over the course of hours in order to assess
parameters such as their retention time in islets, potential
migration between islets or interactions with the vasculature.
Interpretation
Although we wish to avoid overinterpretation of the presented
dataset, we observed a low overall frequency of prolonged
leukocyte-beta cell interactions. This is consistent with our earlier
notion that most beta cells in this model die by cytokine-mediated
effects rather than through perforin[30]. The observation that a
small fraction of the cells does arrest in contact with beta cells for
extended time periods is reminiscent of the results obtained in
tumor models, where a recent study suggested that CTL establish
interactions with tumor cells lasting an average of 6 hours [25].
However, it remains uncertain whether these stable contacts
represent beta cell killing or rather antigen recognition, although
the highly activated memory phenotype of the infiltrating
population may suggest the former event. Our studies also suggest
that beta cell death requires the presence of considerable numbers
of activated CD8 T cells patrolling in the immediate vicinity of the
islet site. The fact that actual beta cell death was only rarely
observed is in line with our data in the conventional RIP-
LCMV.GP model (manuscript in preparation). This may in part
explain why T1D development in humans requires several years,
particularly when the substantially lower degree of insulitis is taken
in consideration as compared to mouse models [18]. Additionally,
there likely is a delay between apoptosis commitment and loss of
GFP signal, which may lead to an underestimation of ‘dying’ cell
numbers at any given time.
Conclusion
In summary, we have developed a novel approach for live in vivo
assessment of diabetogenic immune responses in the pancreas and
islets of Langerhans under physiological conditions. We believe
this will greatly enhance our understanding of the kinetic events




We crossed B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J mice[17]
mice to P14 mice[31], which express a TCR specific for the GP33
CD8 epitope of the LCM virus. Mice expressing GP antigen from
the LCMV-WE [32] strain under control of the rat insulin
promoter (RIP-GP) were bred to a strain with beta cell-restricted
GFP expression (MIP-GFP)[33]. For visualization of dendritic
cells, mice expressing eYFP under the control of the CD11c
promoter were used[19] and bred to the MIP-GFP/RIP-GP
strain. All animal procedures were approved by the Animal Care
Committee of the La Jolla Institute for Allergy and Immunology
(protocol nr. AP121-MvH3-0510).
Diabetes induction protocol
On day 0, a single cell suspension of 1.5*10(7) P14 splenocytes
were transferred into recipient mice via retroorbital injection. On
day 1 and 3, mice were intraperitoneally injected with 2 mg of
GP33 peptide (Abgent, NH2-KAVYNFATM-COOH) in ultra-
pure water containing 50 ug of CpG adjuvant (Sigma). Finally, on
day 6, mice received 500 ug of polyinosinic:polycytidylic acid (Poly
I:C) i.p. (Sigma). All imaging was done on day 7 and 8.
Flow cytometry
Single cell suspensions were prepared from spleen, pancreatic
draining lymph nodes and pancreas. Red blood cell lysis was
performed on splenocyte preparations. All antibodies used were
purchased from BD. For intracellular cytokine staining, cells were
restimulated with GP33 antigen for 5 hours in the presence of
Brefeldin A (GolgiPlug, BD), stained for surface markers and
subsequently fixed and permeabilized (Cytofix/Cytoperm, BD) for
intracellular staining. Acquisition was performed on an LSRII flow
cytometer (BD).
Surgery and temperature control
Mice were injected with an initial dose of 90 mg/kg ketamine
hydrochloride and 15 mg/kg xylazine hydrochloride, which we
previously titrated for efficient and safe induction of long-term
anesthesia. Mice were given half this dose approximately every 45
minutes. The abdominal area was shaved and a longitudinal
incision was made at the site of the spleen. The spleen was gently
exposed with the pancreatic tail region attached and the splenic
vessels were cauterized and splenectomy was performed. The
edges of the pancreatic tail region were attached with surgical glue
(Histoacryl, Braun) to the pedestal of a custom-made imaging
reservoir. The imaging reservoir’s temperature was controlled by a
recirculation system based on a Gaymar T/Pump. Local
temperature at the pedestal was checked with a sensitive probe
(Warner instruments). Heart rate and arterial oxygen saturation
were monitored using a MouseOx pulse oximeter (Starr Life
Sciences Corp) and were found to be similar in animals
undergoing surgery as compared to anesthetized controls.
Two-photon imaging and analysis
We used a Leica SP5 microscope system equipped with an IR
Laser Chameleon ultra ps, tunable from 690 to 1040 nm. For this
study we used 3 channels with non-descanned detectors with filter
sets suitable for separation of GFP (513/17 nm), eYFP (542/27)
and DsRED (692/40 nm) in combination with 520 nm and
560 nm dichroic mirrors. We used an Olympus Super 20
(XLUMPLFL20XW, NA0.95) water dipping objective controlled
by a piezo Z-focus element (Piezosystem Jena). At 900 nm
excitation wavelength, photon penetration and efficient detection
is up to 250 mm deep into the tissue. Laser power at the sample
was 220 mW and was determined using a Thorlabs PM100D
power meter after galvo-scanning was stopped (thus parking the
beam) and AOTF blanking was shut off. Post-acquisition
enhancement (i.e. ‘normalization’ or altering the range of pixel
intensity values for viewing purposes), MIP and panel combination
were performed using ImageJ. The Turboreg and Stackreg
plugins[34] were used for registration within Z-stacks (i.e.
elimination of breathing artifact). 3D tracking was performed
using Imaris (Bitplane) after correction for tissue drift. True
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cellular contact was confirmed by looking at the individual Z-
planes. In most movies, spectral overlap at the islet site was
corrected for by subtracting signal from the ‘red’ from the ‘green’
channel, rendering all islets uniformly green for the sake of clarity.
Finally, image sequences were converted to TIFF or AVI format.
Pixel width and height (w/h) are provided in microns for each
image and movie in the legends.
The confinement ratio corresponds to the ratio of the distance
between the initial and the final positions of each cell to the total
distance covered by the same cell. The arrest coefficient is defined
as the proportion of time each cell’s instantaneous velocity
(calculated for every time interval) is ,3 mm/min.
Visualization of vasculature was achieved by the i.v. injection of
250 mg of 70 kDa Texas-Red labeled dextran in PBS (Invitrogen).
Supporting Information
Movie S1 Imaging islets in the normal pancreas. 3D
rendition of a normal islet as visualized in vivo by two-photon
imaging. Note the coherent beta cell architecture and uniform
GFP expression. Gridlines are 50 mm apart. For xyz dimensions
see figure legend 1C.
(AVI)
Movie S2 Imaging blood flow in the normal pancreas
ascertains physiologic conditions. In order to ascertain that
local vascular supply is fully maintained, pancreatic islets (green)
and their surrounding microvessels (red) were captured at high
frame rates (insets represent single z-planes at 9fps) in normal
animals. Blood flow and vascular integrity are shown here in 2
distinct pancreatic regions (Region 1/2 are MIPs from 43 and 35
planes respectively, each at 3 mm intervals) from a single
representative animal. White scale bars are 100 mm. Pixel w/h
for overview images is 1.5 mm, for insets 1 mm.
(AVI)
Movie S3 Imaging of Diabetogenic Immunity in a
Peptide-Induced Transfer Model. Inflamed islets (green)
are imaged at several stages of beta cell decay with varying levels of
diabetogenic infiltrate (red). All movies were acquired at day 7–8
after cell transfer, right before clinical diabetes onset. For xyz
dimensions, see figure legend 3. Time resolution is 1 minute.
(AVI)
Movie S4 Imaging of leukocyte-beta cell interactions in
a peptide-induced transfer model. Isosurface rendering of
leukocytes (red) interacting with beta cells (green), derived from the
raw fluorescence data presented in Movie S3. Bars in lower left
corner are 10 mm. Time resolution is 1 minute.
(AVI)
Movie S5 Dynamics of pancreatic dendritic cells under
steady-state conditions. Dendritic cells (yellow) can be seen in
the normal pancreas at relatively low densities, in no particular
association with the islets (left panel). Grid lines are 50 mm apart.
Injection of Texas-Red labeled dextran (magenta) reveals the
dense vascular network in the pancreas. The dendritic cells
constantly engage in interactions with the local microvasculature
(right panels). For xyz dimensions, see figure legend 4. Time
resolution is 1 minute.
(AVI)
Movie S6 Imaging of pancreatic dendritic cells during
diabetes development. Visualization of dendritic cell (green,
left panel; yellow, middle and right panel) recruitment to inflamed
islets (left panel, white arrow). Once the DC enter the islet site, they
virtually arrest and remain wedged in and around the islet for
prolonged periods of time (middle-right panel). Real time injection of
Texas-Red dextran (red) was performed to reveal the islet
vasculature. Grid lines are 50 mm apart. All movies are 1 minute
interval sequences containing MIPs of 30 planes spaced 6 mm
apart and with pixel w/h of 1.5 mm.
(AVI)
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